Skip to content
In English |
En español
Search
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -10 of 101
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
Phase II-III Chemotherapy with BLEO/DTIC/VBL/ADR/PRED or NM/VCR/PCB/PRED Plus Radiotherapy for Advanced Hodgkin's Disease
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Treatment
Closed
no age specified
DFCI-75100
2.
Phase III Pilot Study of Alternating Courses of MOPP and ABDV plus Radiotherapy with or without Levamisole for Advanced Hodgkin's Disease
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Completed
no age specified
MSKCC-75104
Last Modified:
3/9/2004
3.
Phase III Study of Topical Therapy of Psoralen With Phototherapy (PUVA), Nitrogen Mustard (Mechlorethamine HCL) Chemotherapy, or Total Skin Electron Beam (TSE) Alone vs One Topical Therapy Combined With Interferon Alfa-2b for Cutaneous T-Cell Lymphoma (CTCL)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Completed
18 and over
NCI
ECOG-1495
E1495
Last Modified:
9/28/2006
 
First Published:
8/1/1998
4.
Phase III Randomized Study of Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine (ABVD) Versus Doxorubicin, Vinblastine, Vincristine, Bleomycin, Mechlorethamine, Etoposide, and Prednisone (Stanford V) With or Without Radiotherapy in Patients With Locally Extensive or Advanced Hodgkin's Lymphoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
16 and over
NCI
ECOG-2496
CAN-NCIC-HD7, CALGB-59905, SWOG-E2496, E2496, NCT00003389, HD7
5.
Phase III Chemotherapy with MOPP (NM/VCR/PCB/PRED) vs OPP (VCR/PCB/PRED) for Recurrent Brain Tumors in Children (Summary last modified 06/97)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Completed
18 and under
NCI
POG-7621
Last Modified:
7/19/2007
6.
Phase III Chemotherapy with BCNU/CTX/VBL/PCB/PRED Followed by NM/VCR/PCB/PRED for Hodgkin's Disease
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
no age specified
SEG-340
7.
Phase III Chemotherapy with MOPP plus BLEO vs MOPP plus ADR/BLEO for Remission Induction of Advanced Hodgkin's Disease
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Completed
no age specified
NCI
SWOG-7406
MDAR-117
Last Modified:
7/1/1997
8.
Radiotherapy plus Chemotherapy with NM/VCR/PCB/PRED/BLEO vs Chemotherapy for Stage III A & B Hodgkin's Disease - A Phase III Study (Summary Last Modified 07/97)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Completed
no age specified
NCI
SWOG-7518
MDAR-24
9.
Phase III Chemotherapy with NM/VCR/PCB/PRED and Low-Dose BLEO for Hodgkin's Disease Stages IIIB, IVA and IVB
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
no age specified
NCI
SWOG-774/775
10.
Phase III Evaluation of Chemotherapy with MOPP vs Chemotherapy with CCNU/VBL/PRED for Adult Advanced Hodgkin's Disease
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Completed
over 18
WCG-130
Select All on One Page
1
2
3
4
Next >
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute